Impact of Visual Field Restriction on Visual Exploration
NCT ID: NCT04360291
Last Updated: 2020-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
45 participants
OBSERVATIONAL
2019-11-04
2021-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to improve the accessibility and autonomy of visually impaired people in museums and to allow each observer to feel the visual and emotional experience closest to the original work of the artist, it is essential to identify the modifications. perceptive generated by the constriction of vision
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
NCT04281732
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NCT05141604
Motor Performance Improvement After Visual Rehabilitation
NCT06698172
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
NCT06914505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Through the recording of eye movements, the investigators compare the differences in visual explorations of people with retinitis pigmentosa and healthy people with or without a simulated deficit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers
Healthy volunteers
Eye tracker
In visual search tasks, participants will sit in front of a screen and observe during each visual scene for a maximum of 45 seconds. Their eye movements will be recorded
Retinopathy pigment
Patients with retinopathy pigment
Eye tracker
In visual search tasks, participants will sit in front of a screen and observe during each visual scene for a maximum of 45 seconds. Their eye movements will be recorded
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye tracker
In visual search tasks, participants will sit in front of a screen and observe during each visual scene for a maximum of 45 seconds. Their eye movements will be recorded
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 and \<65 years
* Binocular visual acuity ≥8 / 10th or ≤ +0.10 logMAR
* Comprehension of the written and spoken French language
* Signed consent to participate in the study
* Health insurance affiliation
* Visit to an ophthalmologist less than a year old
* Retinopathy pigmentary dystrophy rods-cones.
* Binocular visual acuity ≥4 / 10 (≤0.4 logMAR).
* Horizontal diameter of the residual Goldmann field of view ≤ 25 ° of binocular diameter at III4.
* Comprehension of the French language, written or oral.
* Signed consent
* Visual assessment less than 6 months old
Exclusion Criteria
* Ocular pathology that may interfere with planned assessments
* Treatment that may interfere with planned assessments
* Participation in another study that may interfere with this study.
* Severe pathology unbalanced or interfering with planned assessments.
* Neurological deficit including history of epileptic pathology, photosensitive epilepsy, sensory-motor coordination disorders, vestibular or cerebellar pathology
* Inability to give consent personally.
* Adults protected by law.
Groupe 2
* Pregnant or nursing woman.
* Ocular pathology that may interfere with planned assessments.
* Treatment that may interfere with planned assessments.
* Severe pathology unbalanced or interfering with planned assessments.
* Participation in another study that may interfere with this study.
* Neurological deficit including antecedent of epileptic pathology, photosensitive epilepsies, non-visual sensory disturbances, motor disorders, or sensorimotor coordination disorders, vestibular or cerebellar pathology.
* Inability to give consent personally.
* Adults protected by law.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avinoam Safran
Role: PRINCIPAL_INVESTIGATOR
Institut de la vision
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de la vision
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01198-49
Identifier Type: OTHER
Identifier Source: secondary_id
P19-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.